These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 16888083)

  • 21. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis.
    Ohkawara T; Mitsuyama K; Takeda H; Asaka M; Fujiyama Y; Nishihira J
    Scand J Gastroenterol; 2008; 43(12):1497-504. PubMed ID: 18663662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice.
    Villegas I; Alarcón de la Lastra C; Orjales A; La Casa C
    Int Immunopharmacol; 2003 Dec; 3(13-14):1731-41. PubMed ID: 14636824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
    Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
    Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis.
    Farooq SM; Stillie R; Svensson M; Svanborg C; Strieter RM; Stadnyk AW
    J Pharmacol Exp Ther; 2009 Apr; 329(1):123-9. PubMed ID: 19131582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
    Lu F; Fernandes SM; Davis AE
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice.
    Hans W; Schölmerich J; Gross V; Falk W
    Eur Cytokine Netw; 2000 Mar; 11(1):67-74. PubMed ID: 10705301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of metallothionein in murine experimental colitis.
    Tsuji T; Naito Y; Takagi T; Kugai M; Yoriki H; Horie R; Fukui A; Mizushima K; Hirai Y; Katada K; Kamada K; Uchiyama K; Handa O; Konishi H; Yagi N; Ichikawa H; Yanagisawa R; Suzuki JS; Takano H; Satoh M; Yoshikawa T
    Int J Mol Med; 2013 May; 31(5):1037-46. PubMed ID: 23467591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice.
    Nishitani Y; Tanoue T; Yamada K; Ishida T; Yoshida M; Azuma T; Mizuno M
    Int Immunopharmacol; 2009 Nov; 9(12):1444-51. PubMed ID: 19733697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mTOR inhibitor is efficacious in a murine model of colitis.
    Bhonde MR; Gupte RD; Dadarkar SD; Jadhav MG; Tannu AA; Bhatt P; Bhatia DR; Desai NK; Deore V; Yewalkar N; Vishwakarma RA; Sharma S; Kumar S; Dagia NM
    Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1237-45. PubMed ID: 18927209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidants as novel therapy in a murine model of colitis.
    Oz HS; Chen TS; McClain CJ; de Villiers WJ
    J Nutr Biochem; 2005 May; 16(5):297-304. PubMed ID: 15866230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
    Cooper HS; Murthy SN; Shah RS; Sedergran DJ
    Lab Invest; 1993 Aug; 69(2):238-49. PubMed ID: 8350599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextran sulfate sodium-induced colitis generates a transient thymic involution--impact on thymocyte subsets.
    Fritsch Fredin M; Elgbratt K; Svensson D; Jansson L; Melgar S; Hultgren Hörnquist E
    Scand J Immunol; 2007 May; 65(5):421-9. PubMed ID: 17444952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
    Martín AR; Villegas I; Alarcón de la Lastra C
    Inflamm Res; 2005 Apr; 54(4):145-51. PubMed ID: 15883736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
    Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis.
    Sasaki M; Bharwani S; Jordan P; Joh T; Manas K; Warren A; Harada H; Carter P; Elrod JW; Wolcott M; Grisham MB; Alexander JS
    J Pharmacol Exp Ther; 2003 Apr; 305(1):78-85. PubMed ID: 12649355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of CPI-17 downregulation in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model.
    Sato K; Ohkura S; Kitahara Y; Ohama T; Hori M; Sato M; Kobayashi S; Sasaki Y; Hayashi T; Nasu T; Ozaki H
    Neurogastroenterol Motil; 2007 Jun; 19(6):504-14. PubMed ID: 17564632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.
    Schmidt N; Gonzalez E; Visekruna A; Kühl AA; Loddenkemper C; Mollenkopf H; Kaufmann SH; Steinhoff U; Joeris T
    Gut; 2010 Jul; 59(7):896-906. PubMed ID: 20581238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.